The Changing Tasks of Medicine and Dermatology in the Twenty-First Century: The Need for Improved Information Capture Tools and Processes Howa YeungYin LiRobert A. Swerlick Commentary Open access 13 October 2023 Pages: 2479 - 2486
Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm Rahul MassonCharlotte Y. JeongJennifer L. Hsiao Review Open access 22 September 2023 Pages: 2487 - 2526
Topical Treatment for the Management of Mild-to-Moderate Psoriasis: A Critical Appraisal of the Current Literature Maria Concetta FargnoliClara De SimonePiergiacomo Calzavara-Pinton Review Open access 22 September 2023 Pages: 2527 - 2547
Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials Hannah PentonSayeli JayadeJorge Puelles Review Open access 25 September 2023 Pages: 2549 - 2571
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status Thomas B. CasaleAna Maria Gimenez-ArnauMarcus Maurer Review Open access 30 September 2023 Pages: 2573 - 2588
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis April W. ArmstrongSang Hee ParkViktor Chirikov Original Research Open access 31 July 2023 Pages: 2589 - 2603
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis April W. ArmstrongSang Hee ParkViktor Chirikov Correction Open access 18 October 2023 Pages: 2605 - 2607
The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany Maria KahnSteffeni PapukchievaBenjamin Friedrich Original Research Open access 14 September 2023 Pages: 2609 - 2620
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study Diamant ThaçiChristos TziotziosErnest Law Original Research Open access 14 September 2023 Pages: 2621 - 2634
Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database Joseph F. MerolaDhaval PatilAlice B. Gottlieb Original Research Open access 19 September 2023 Pages: 2635 - 2648
Burden of Herpes Zoster Among Patients with Psoriasis in the United States David SingerPhilippe Thompson-LeducSara Poston Original Research Open access 22 September 2023 Pages: 2649 - 2668
Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study Mehdi SowlatiSilviu-Horia MorariuCristian Gainaru Original Research Open access 23 September 2023 Pages: 2669 - 2679
Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective Jinsui ZhangZemin XiaWen Chen Original Research Open access 23 September 2023 Pages: 2681 - 2696
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis Michael J. CorkDiamant ThaçiNoah A. Levit Original Research Open access 26 September 2023 Pages: 2697 - 2719
Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2 Byung Soo KimSeong Jin JoTsen-Fang Tsai Original Research Open access 26 September 2023 Pages: 2721 - 2737
Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry Robert R. McLeanAdam P. SimaApril Armstrong Original Research Open access 27 September 2023 Pages: 2739 - 2751
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry Robert R. McLeanAdam P. SimaApril Armstrong Original Research Open access 27 September 2023 Pages: 2753 - 2768
Thermal Therapy Modulation of the Psoriasis-Associated Skin and Gut Microbiome Serena ManaraFrancesco BeghiniMario Cristofolini Original Research Open access 28 September 2023 Pages: 2769 - 2783
Neurotrophin-4 and Brain-Derived Neurotrophic Factor Serum Levels in Renal Transplant Recipients with Chronic Pruritus Kinga TyczyńskaPiotr K. KrajewskiJacek C. Szepietowski Original Research Open access 01 October 2023 Pages: 2785 - 2796
Navigating the Multidimensional Impact of Living with Hidradenitis Suppurativa: An In-Depth Netnographic Study on Social Media Platforms Ericles Andrei BelleiAndré Vicente Esteves de CarvalhoFelipe Garutti Thies Original Research Open access 04 October 2023 Pages: 2797 - 2815
Evaluating the Appropriateness of Existing Health-Related Quality of Life Measures in Lichen Planus Aoife Mahon-SmithGeorge SkingleySantiago G. Moreno Original Research Open access 05 October 2023 Pages: 2817 - 2837
Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis April W. ArmstrongRichard B. WarrenMatthias Augustin Original Research Open access 06 October 2023 Pages: 2839 - 2857
Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis Ana-Maria OrbaiSoumya D. ChakravartyJoseph F. Merola Brief Report Open access 15 September 2023 Pages: 2859 - 2868
Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data Axel De GreefRomane ThirionMarie Baeck Brief Report Open access 17 September 2023 Pages: 2869 - 2877
Responsiveness and Minimal Clinically Important Difference of the Infants and Toddlers Dermatology Quality of Life Questionnaire Pavel V. ChernyshovServando E. MarronLucia Tomas-Aragones Brief Report Open access 20 September 2023 Pages: 2879 - 2893
Public Perceptions, Factors, and Incentives Influencing Patient Willingness to Share Clinical Images for Artificial Intelligence-Based Healthcare Tools Sophia LySophia Reyes-HadsallArash Mostaghimi Brief Report Open access 22 September 2023 Pages: 2895 - 2902
Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation Riley K. SpencerJoy Q. JinTina Bhutani Brief Report Open access 05 October 2023 Pages: 2903 - 2909
Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA Andrew BlauveltAlyssa GarreltsMeghan Feely Letter Open access 26 September 2023 Pages: 2911 - 2916
Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA Timothy FitzgeraldMaryia ZhdanavaSteven R. Feldman Letter Open access 26 September 2023 Pages: 2917 - 2923
Correction to: Real-World Treatment Patterns in Patients with Vitiligo in the United States David RosmarinAhmed M. SolimanChao Li Correction Open access 02 September 2023 Pages: 2925 - 2925
Correction to: Long-Term Effectiveness and Drug Survival of Secukinumab in Vietnamese Patients with Psoriasis: Results from a Retrospective ENHANCE Study Hao Trong NguyenNhi Thi Uyen PhamThao Thi Phuong Vu Correction Open access 03 September 2023 Pages: 2927 - 2927